Literature DB >> 16097024

Electrophoresis-assisted open-tubular liquid chromatography/mass spectrometry for the analysis of lipooligosaccharide expressed by Campylobacter jejuni.

Jianjun Li1, Michiaki Koga, Denis Brochu, Nobuhiro Yuki, Kenneth Chan, Michel Gilbert.   

Abstract

Lipooligosaccharide (LOS) is the major component of the external membrane of Campylobacter jejuni. LOS contains a hydrophobic moiety, lipid A, and a hydrophilic moiety, oligosaccharide. Due to the unique mimicry of human ganglioside structures and potential involvement in the induction of the autoimmune polyneuropathies, Guillain-Barré and Miller Fisher syndromes, the structural characterization of C. jejuni LOS has received much attention. We have been using capillary zone electrophoresis-mass spectrometry to analyze O-deacylated LOS from C. jejuni. In an attempt to optimize the separation conditions, the effect of methanol on the separation of LOS was investigated. It was found that methanol resulted in stronger adsorption of LOS onto the wall of fused-silica capillary. In this paper, we applied this adsorption to perform electrophoresis-assisted open-tubular liquid chromatography electrospray mass spectrometry for the analysis of O-deacylated LOS mixtures from C. jejuni. The analytical potential of the proposed strategy for the analysis of O-deacylated LOS glycoforms from five bacterial colonies is demonstrated. Online tandem mass spectrometry is shown to provide a powerful tool for characterization of variations in the hexosamine backbone, phosphorylation of the lipid A, and sialic acid sequence information.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16097024     DOI: 10.1002/elps.200500145

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  7 in total

1.  GQ1b-seronegative Fisher syndrome: clinical features and new serological markers.

Authors:  Michiaki Koga; Michel Gilbert; Masaki Takahashi; Jianjun Li; Koichi Hirata; Takashi Kanda; Nobuhiro Yuki
Journal:  J Neurol       Date:  2012-01-05       Impact factor: 4.849

2.  Genetics behind the Biosynthesis of Nonulosonic Acid-Containing Lipooligosaccharides in Campylobacter coli.

Authors:  Mirko Rossi; Michel Gilbert; Warren Wakarchuk; Alejandra Kolehmainen; Jacek Stupak; Jianjun Li
Journal:  J Bacteriol       Date:  2019-03-26       Impact factor: 3.490

3.  The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion.

Authors:  Rogier Louwen; Astrid Heikema; Alex van Belkum; Alewijn Ott; Michel Gilbert; Wim Ang; Hubert P Endtz; Mathijs P Bergman; Edward E Nieuwenhuis
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

4.  Rapid method for sensitive screening of oligosaccharide epitopes in the lipooligosaccharide from Campylobacter jejuni strains isolated from Guillain-Barré syndrome and Miller Fisher syndrome patients.

Authors:  Monika Dzieciatkowska; Xin Liu; Astrid P Heikema; R Scott Houliston; Alex van Belkum; Elke K H Schweda; Michel Gilbert; James C Richards; Jianjun Li
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

5.  Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.

Authors:  Michiaki Koga; Michel Gilbert; Jianjun Li; Nobuhiro Yuki
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.

Authors:  Zhahirul Islam; Michel Gilbert; Quazi D Mohammad; Kevin Klaij; Jianjun Li; Wouter van Rijs; Anne P Tio-Gillen; Kaisar A Talukder; Hugh J Willison; Alex van Belkum; Hubert P Endtz; Bart C Jacobs
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

7.  Whole Genome Sequencing and Multiplex qPCR Methods to Identify Campylobacter jejuni Encoding cst-II or cst-III Sialyltransferase.

Authors:  Jason M Neal-McKinney; Kun C Liu; Karen C Jinneman; Wen-Hsin Wu; Daniel H Rice
Journal:  Front Microbiol       Date:  2018-03-16       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.